Trial intelligence / Profile preview

Aspirin Dosing for Preeclampsia Prevention

NCT03726177Unknown

Sponsor
Aswan University Hospital
Start
Dec 2018
Primary completion
Nov 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of aspirin in preeclampsia (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Number of Participants With early Preeclampsia at 6 months. Status: unknown.

02

Drugs

aspirin
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT03726177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03726177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call